News & Analysis on Clinical Trial Services & Contract Research And Development
The use of animal testing in pharmaceutical research and development is to be revised after the UK government announced it was to establish a national centre to reduce use and raise standards of animal welfare, writes Wai Lang Chu.
Ministers at the Council of the European Union dashed hopes that an EU-wide 'Community Patent' might be in the offing by voting against the measure at last week's EU Competitiveness Council meeting.
Respironics, a US-based company specialising in sleep and ventilation products, is to make a $44.6 million (€37.3m) cash offer for Profile Therapeutics of the UK.
UK-based chemistry specialist Syrris has developed a new microreactor that, it claims, can speed up the optimisation of process reactions used in the drug industry.
Belgian group UCB, fresh from making an offer for UK biotech company Celltech, has announced plans to sell off its chemicals unit and become a pharmaceuticals pure play, reports Phil Taylor.
US-headquartered generics manufacturer Ivax has cleared one obstacle in its battle to acquire a majority stake in Polish drugmaker Polfa Kutno.
The use of animal testing in pharmaceutical research and development is to be revised after the UK government announced it was to establish a national centre to reduce use and raise standards of animal welfare.